Daiichi Life Insurance Co. Ltd. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 8,244 shares of the company’s stock, valued at approximately $3,214,000.
Several other large investors have also bought and sold shares of HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC boosted its position in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the period. Jump Financial LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $2,073,000. Finally, Sei Investments Co. raised its position in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have commented on HCA. JPMorgan Chase & Co. lowered their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday. TD Cowen decreased their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Oppenheimer reduced their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Wells Fargo & Company increased their price target on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Finally, Barclays cut their price objective on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $462.64.
HCA Healthcare Stock Down 0.0%
NYSE:HCA opened at $429.08 on Monday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market cap of $92.90 billion, a P/E ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The business has a 50 day moving average price of $397.16 and a two-hundred day moving average price of $443.77.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.84 earnings per share. As a group, analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
